On February 24, 2021 I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, reported its participation in the following conferences in March (Press release, I-Mab Biopharma, FEB 24, 2021, View Source [SID1234575570]). Details of the conferences and management presentation are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright Global Life Sciences Conference (Virtual)
Presentation: Tuesday, March 9, 2021 at 7:00 a.m. EST
Presenter: Mr. Jielun Zhu, Director and Chief Financial Officer
Webcast link: View Source The webcast will also be available under "Event Calendar" on IMAB’s IR website at View Source
One-on-one meetings: March 9-10, 2021
Management participants: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director
For more information, please contact your H.C. Wainwright representative.
24th Credit Suisse Asian Investment Conference (Virtual)
Management participants: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director
One-on-one and small group meetings: March 22-26, 2021
For more information, please contact your Credit Suisse representative.
Morgan Stanley Hong Kong Summit (Virtual)
Management participants: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director
One-on-one and small group meetings: March 29-31, 2021